Building a Bridge
Biocom California’s Japan initiative aims to build a bridge between life science companies in Japan and California, as well as create greater awareness of opportunities in Japan for our members. Biocom California’s Japan office is integral in our mission to develop several key relationships between Biocom California and major life science entities.
An Update on BioJapan 2022, October 12-14:
While Biocom California will not be participating in the BioJapan Conference this year, we wanted to provide resources for members still interested in attending, either as an exhibitor, partnering, or visitor. To note, because COVID-19 precautionary requirements are taken in Japan, please reach out to the Japan Consulate General to find up-to-date information.
It all started with Japan Airlines’ announcement in 2013 that it would begin a direct flight from San Diego to Tokyo. Biocom California had long been making inroads into the Asian life science marketplace, but the easy direct flight is ultimately what paved the way for a series of business deals that have significantly boosted Japan’s pharmaceutical presence in San Diego and across California.
Tony Fujita & Joe Panetta
Biocom California’s Japan Consulting
3-1-13 8fl, Nishi-Ikebukuro
Toshima-ku, Tokyo, 171-0021 Japan